Patents by Inventor Dominique Le Beller

Dominique Le Beller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190345199
    Abstract: The present invention relates to novel antimicrobial compounds and their uses, in particular as medicament, disinfectant, preservative or phytosanitary agent.
    Type: Application
    Filed: January 2, 2018
    Publication date: November 14, 2019
    Inventor: DOMINIQUE LE BELLER
  • Patent number: 10308683
    Abstract: The invention relates to a new bicyclic lipolantipeptide, representing a new class of lantipeptide, and salts thereof, their preparation from a culture of a Microbacterium arborescens, and their use as antimicrobial agent in the prevention and treatment of infections in humans, animals or plants.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: June 4, 2019
    Assignee: DEINOVE
    Inventors: Josef Aszodi, Denis Carniato, Dominique Le Beller, Guillaume Lesquame, Marie-Helene Quernin
  • Publication number: 20180201646
    Abstract: The invention relates to a new bicyclic lipolantipeptide, representing a new class of lantipeptide, and salts thereof, their preparation from a culture of a Microbacterium arborescens, and their use as antimicrobial agent in the prevention and treatment of infections in humans, animals or plants.
    Type: Application
    Filed: July 1, 2016
    Publication date: July 19, 2018
    Inventors: JOSEF ASZODI, DENIS CARNIATO, DOMINIQUE LE BELLER, GUILLAUME LESQUAME, MARIE-HELENE QUERNIN
  • Publication number: 20180187216
    Abstract: The present invention relates to the use of a bacterium of the genus Microbacterium for the production of a compound endowed with antibacterial activity.
    Type: Application
    Filed: July 1, 2016
    Publication date: July 5, 2018
    Inventors: Pascal DHULSTER, Dominique LE BELLER, Jean-Paul LEONETTI, Huges MANDAVID, Prémavathy LEVASSEUR, Marjorie VALENDUC
  • Patent number: 6642391
    Abstract: A compound named Amycomycin of the formula: is described, as well as its pharmaceutically acceptable salts and derivatives, in all their stereoisomeric and tautomeric forms. The compound is obtained by growing the microorganism Amycolatopsis species ST101170 (DSM 12216) and is useful as a pharmaceutical, particularly as an antibiotic.
    Type: Grant
    Filed: December 7, 2000
    Date of Patent: November 4, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Cordula Hopmann, Michael Kurz, Heinrich Decker, Dominique Le Beller, Jozsef Aszodi
  • Publication number: 20020183267
    Abstract: The present invention relates to a compound named Vancoresmycin which is obtainable by cultivation of the microorganism HIL-006734 (DSM 12216), and to its pharmaceutically acceptable salts. The present invention further relates to a process for the production of Vancoresmycin, to the microorganism HIL-006734 (DSM 12216), to the use of Vancoresmycin and its pharmaceutically acceptable salts as pharmaceuticals, and in particular to their use as antibiotics, and to pharmaceutical compositions comprising Vancoresmycin or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 25, 2002
    Publication date: December 5, 2002
    Inventors: Nirogi Venkata Satya Ramakrishna, Ravi Gaianan Bhat, Eyyammadichiyil Sankaranarayanan Sreekumar, Erra Koteswara Satya Vijayakumar, Shantilal Dayaram Naker, Uttara Vinayak Oak, Rajendra Prakash Tanpure, Cordula Hopmann, Michael Kurz, Joachim Wink, Gerhard Seibert, Dominique Le Beller, Jozsef Aszodi
  • Patent number: 6387943
    Abstract: The present invention relates to a compound named Vancoresmycin which is obtainable by cultivation of the microorganism HIL-006734 (DSM 12216), and to its pharmaceutically acceptable salts. The present invention further relates to a process for the production of Vancoresmycin, to the microorganism HIL-006734 (DSM 12216), to the use of Vancoresmycin and its pharmaceutically acceptable salts as pharmaceuticals, and in particular to their use as antibiotics, and to pharmaceutical compositions comprising Vancoresmycin or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: May 14, 2002
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Nirogi Venkata Satya Ramakrishna, Ravi Gajanan Bhat, Eyyammadichiyil Sankaranarayanan Sreekumar, Erra Koteswara Satya Vijayakumar, Shantilal Dayaram Naker, Uttara Vinayak Oak, Rajendra Prakash Tanpure, Cordula Hopmann, Michael Kurz, Joachim Wink, Gerhard Seibert, Dominique Le Beller, Jozsef Aszodi
  • Publication number: 20010018450
    Abstract: A compound named Amycomycin of the formula: 1
    Type: Application
    Filed: December 7, 2000
    Publication date: August 30, 2001
    Inventors: Cordula Hopmann, Michael Kurz, Heinrich Decker, Dominique Le Beller, Jozsef Aszodi
  • Patent number: 5994307
    Abstract: This invention relates to the antibiotic feglymycin, as well as processes for its preparation and use. Feglymycin is represented by the structural formula (SEQ. ID. NO.
    Type: Grant
    Filed: December 2, 1998
    Date of Patent: November 30, 1999
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Laszlo Vertesy, Martin Knauf, Joachim Wink, Dieter Isert, Wilhelm Stahl, Gunther Riess, Jozsef Aszodi, Dominique Le Beller
  • Patent number: 5891851
    Abstract: This invention relates to the antibiotic feglymycin, as well as processes for its preparation and use.
    Type: Grant
    Filed: December 11, 1997
    Date of Patent: April 6, 1999
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Laszlo Vertesy, Martin Knauf, Joachim Wink, Dieter Isert, Wilhelm Stahl, Gunther Riess, Jozsef Aszodi, Dominique Le Beller